Quick filters:
Open Data
Open Code
Pre-registered
Funding Declared
COI Declared
Open Access
Clear Filters
JAK inhibition as a new treatment strategy for patients with COVID-19.
Biochem Pharmacol
(Unknown)
Published: 2022
Targeting immunosuppression by TGF-β1 for cancer immunotherapy.
Biochem Pharmacol
(Unknown)
Published: 2021
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interacti…
Biagioli M; Marchianò S; Roselli R; Di Giorgio C; Bellini R; Bordoni M; Gidari A; Sabbatini S; Francisci D; Fiorillo B; Catalanotti B; Distrutti E; Carino A; Zampella A; Costantino G; Fiorucci S.
Biochem Pharmacol
(Unknown)
Published: 2021
Animal models for SARS-Cov2/Covid19 research-A commentary.
Biochem Pharmacol
(Unknown)
Published: 2021
The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro.
Song J; Zhang L; Xu Y; Yang D; Zhang L; Yang S; Zhang W; Wang J; Tian S; Yang S; Yuan T; Liu A; Lv Q; Li F; Liu H; Hou B; Peng X; Lu Y; Du G.
Biochem Pharmacol
(Unknown)
Published: 2020